Academic literature on the topic 'Anticoagulants'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Anticoagulants.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Anticoagulants"
Shelfer, Janet, David Zapala, and Larry Lundy. "Fall Risk, Vestibular Schwannoma, and Anticoagulation Therapy." Journal of the American Academy of Audiology 19, no. 03 (March 2008): 237–45. http://dx.doi.org/10.3766/jaaa.19.3.8.
Full textJose Vicente Catalá Ripoll, Jose Ángel Monsalve Naharro, Esther Domingo Chiva, Pablo Cuesta Montero, and Jose María Jiménez Vizuete. "Terapia antitrombótica en pacientes con hemorragia intracraneal. ¿Revertimos?" Revista Electrónica AnestesiaR 10, no. 8 (August 31, 2018): 6. http://dx.doi.org/10.30445/rear.v10i8.599.
Full textTeruya, Jun, Aaron G. West, and Mary Nell Suell. "Lupus Anticoagulant Assays: Questions Answered and to Be Answered." Archives of Pathology & Laboratory Medicine 131, no. 6 (June 1, 2007): 885–89. http://dx.doi.org/10.5858/2007-131-885-laaqaa.
Full textMoore, Gary W., Savita Rangarajan, and Geoffrey F. Savidge. "The Activated Seven Lupus Anticoagulant Assay Detects Clinically Significant Antibodies." Clinical and Applied Thrombosis/Hemostasis 14, no. 3 (June 19, 2008): 332–37. http://dx.doi.org/10.1177/1076029607305099.
Full textKADYSEVA, E. R. "Pharmacoeconomic aspects of the use of anticoagulants in a multi-speciality hospital." Practical medicine 20, no. 6 (2022): 58–60. http://dx.doi.org/10.32000/2072-1757-2022-6-58-60.
Full textCahill, Tom, Julie Broughton, Thomas Ferguson, and Stephen Jenkins. "The impact of the introduction of direct oral anticoagulants into a general practice and hospital anticoagulant services: two local service evaluations." British Journal of Healthcare Management 25, no. 6 (June 2, 2019): 1–12. http://dx.doi.org/10.12968/bjhc.2018.0060.
Full textTatarsky, B. A., and N. V. Kazyonnova. "Safety and interaction of direct oral anticoagulants with antiarrhythmic drugs." Russian Journal of Cardiology 26, no. 7 (August 8, 2021): 4482. http://dx.doi.org/10.15829/1560-4071-2021-4482.
Full textManfredini, Mattia, Pier Paolo Poli, Luca Creminelli, Alberto Porro, Carlo Maiorana, and Mario Beretta. "Comparative Risk of Bleeding of Anticoagulant Therapy with Vitamin K Antagonists (VKAs) and with Non-Vitamin K Antagonists in Patients Undergoing Dental Surgery." Journal of Clinical Medicine 10, no. 23 (November 25, 2021): 5526. http://dx.doi.org/10.3390/jcm10235526.
Full textYang, Peiwen. "Analysis of the therapeutic effect and application of anticoagulant drugs." Theoretical and Natural Science 15, no. 1 (December 4, 2023): 188–92. http://dx.doi.org/10.54254/2753-8818/15/20240480.
Full textAnnisa, Lily, Nurfina Dian Kartikawati, and Vitarani Dwi Ananda Ningrum. "Use of anticoagulant drugs for hospitalised patients: A multicentre study." Pharmacy Education 24, no. 3 (May 12, 2024): 286–91. http://dx.doi.org/10.46542/pe.2024.243.286291.
Full textDissertations / Theses on the topic "Anticoagulants"
Lloret, Dominique. "Les anticoagulants circulants spontanés anti facteur VIII:c. à propos d'un cas." Montpellier 1, 1989. http://www.theses.fr/1989MON11228.
Full textLlory, Pierre. "Actualité sur les anticoagulants circulants antithrombinase : incidences en anesthésie-réanimation." Montpellier 1, 1988. http://www.theses.fr/1988MON11372.
Full textMoustafa, Farès. "Risque hémoragique sous anticoagulants : Vers une prise en charge personnalisée." Thesis, Lyon, 2017. http://www.theses.fr/2017LYSES049/document.
Full textIntroduction. Given many risk factors that may influence the risk of hemorrhage underanticoagulant therapy, the concept of personalized medicine could have a favorableimpact in the overall management of these patients.Hypothesis and objective. The hypothesis of this thesis is that the use and analyze of "reallife" registries could allow to define hemorrhagic "profiles" allowing a personalizedmanagement of the patients.Material and method. This thesis work has used two real life registries, the RIETE registry(international, multicentric and prospective register) and RATED (monocentric register).Results. We showed the importance of biological database in the analysis of hemorrhagicevents under anticoagulants with a higher loss of coagulation factors in gastrointestinalbleeding compared with intracranial bleeding under AVK. Conversely, this bleeding risk istwo times lower in case of factor V Leiden mutation. Thanks to the RIETE registry, wewere interested in abnormal uterine bleeding under anticoagulant therapy (few studies inthe literature) with major uterine bleeding only for 0.17% of women. Then, we showed thatfragile patients (CrCl ≤50 mL / min, age ≥75 years or body weight ≤50 kg) have a 2-foldhigher risk for major bleeding. Finally, in order to show the complementarity between datafrom real life registries and randomized trial, we assessed patients normally excluded fromthese randomized trials and also showed a 4-fold higher bleeding risk in these excludedpatients.Conclusion. This thesis work allowed us to demonstrate the interest of working not only onoverall hemorrhages but on each type of hemorrhage separately, with a particular interestto create real life prospective registries with the implementation of bio-bank allowing amore personalized analysis of the intake of patients
Mehta, Akul. "Synthetic, Sulfated, Lignin-Based Anticoagulants." VCU Scholars Compass, 2014. http://scholarscompass.vcu.edu/etd/598.
Full textHababou, Karine. "Les traitements de la maladie thromboembolique : intérêt de l'international normalized ratio (INR) pour leur surveillance." Paris 5, 1991. http://www.theses.fr/1991PA05P089.
Full textCampos, Nelson Leonardo Kerdahi Leite de [UNESP]. "Análise do controle de anticoagulação oral em pacientes portadores de próteses valvares cardícas mecânicas por meio de ambulatório especializado: experiência de 10 anos." Universidade Estadual Paulista (UNESP), 2006. http://hdl.handle.net/11449/100384.
Full textFundação para o Desenvolvimento Médico e Hospitalar (Famesp)
Estudo realizado, com base nos dados do ambulatório, para controle de anticoagulação nos pacientes portadores de próteses valvares cardíacas mecânicas do Serviço de Cirurgia Cardiovascular do Hospital das Clínicas da Faculdade de Medicina de Botucatu, no intervalo de dez anos, com os objetivos: avaliação da resposta à terapêutica profilática anticoagulante; quantificação das complicações tromboembólicas e hemorrágicas, com estratificação de sua gravidade; comparação entre tipos de anticoagulantes orais, doses e efeitos; influência da posição da prótese; presença de fibrilação atrial e tamanho do átrio esquerdo; e análise da estratégia de anticoagulação adotada. Foram incluídos, no estudo, 259 pacientes portadores de próteses mitrais (mitrais), aórticas (aórticos) e mitral e aórticas (mitro-aórticos). Foram analisadas 9714 consultas com valores do tempo de protrombina (em RNI) e dados dos registros hospitalares sobre complicações tromboembólicas e hemorrágicas com graus de gravidade. Os pacientes foram divididos em quatro grupos de acordo com o porcentual de consultas em que a RNI se encontrava dentro do intervalo desejado. Foram estudados dois anticoagulantes (Fenprocumona e Warfarina) e suas dosagens. Foi, também, avaliada a ocorrência de complicações tromboembólicas e hemorrágicas. Os resultados estão apresentados em: número de pacientes com complicações, estudo atuarial e freqüência linearizada de ocorrência de eventos. Os dados obtidos permitiram concluir que: a anticoagulação oral foi mais satisfatória nos aórticos do que nos mitrais e mitro-aórticos; os mitrais apresentaram ocorrência de eventos tromboembólicos semelhante a dos aórticos, porém com maior freqüência de hemorragias; os grupos que tiveram anticoagulação mais estável apresentaram menos complicações; poucas diferenças quanto à ocorrência de...
The study was held using outpatient data collected during 10 years for anticoagulation control of patients with mechanical prosthetic heart valves from the Cardiovascular Surgery Service at the Medical University Hospital in Botucatu city. The objectives were as follows: evaluation of prophylactic anticoagulation therapy, number of thromboembolic and hemorrhagic complications and their severity stratification, assessment of different oral anticoagulants, their effects and dosing, influence of prosthesis position, presence of atrial fibrillation and size of the left atrium, assessment of the anticoagulation strategy. Two hundred and fifty nine patients with mitral (M), aortic (A), mitral and aortic (M-A) prostheses were included in the study. Prothrombin time expressed in terms of international normalised ratio (INR) from 9714 consultations, medical data on thromboembolic and hemorrhagic complications as well as their severity were evaluated. Patients were allocated to four groups according to percentage of consultations which INR was within the target range. Two anticoagulants (Fenprocoumon and Warfarin), their dosing system, thromboembolic and hemorrhagic complications were also evaluated. Results were expressed as: number of patients with complications, actuarial study and linearized rate of events. Conclusions: oral anticoagulation was better in A than in M or M-A patients; M patients presented as many thromboembolic events as A patients although with higher hemorrhagic rate; groups presenting more steady anticoagulation showed fewer complications; there were few differences concerning complications among users of Fenprocoumon and Warfarin; most patients needed lower anticoagulant doses; patients with atrial fibrillation and/or enlarged left atrium presented as many thromboembolic complications as the other studied patients, although with higher... (Complete abstract click electronic access below)
Barrière, Véronique. "Présence d'un anticoagulant circulant chez un insuffisant rénal chronique." Montpellier 1, 1989. http://www.theses.fr/1989MON11217.
Full textPham, Thuy-Hang. "Thérapeutique anticoagulante dans un service de cardiologie : prescription et suivi thérapeutique." Paris 5, 1991. http://www.theses.fr/1991PA05P050.
Full textMueller, Tanja. "Use of direct oral anticoagulants in Scotland." Thesis, University of Strathclyde, 2017. http://digitool.lib.strath.ac.uk:80/R/?func=dbin-jump-full&object_id=28882.
Full textFONDO, JASKIEWICZ MARTINE. "Intoxications secondaires a l'ingestion de raticides anticoagulants." Reims, 1994. http://www.theses.fr/1994REIMM082.
Full textBooks on the topic "Anticoagulants"
L, Poller, and Hirsh Jack 1935-, eds. Oral anticoagulants. London: Arnold, 1996.
Find full textProietti, Riccardo, Ahmed AlTurki, Nicola Ferri, Vincenzo Russo, and T. Jared Bunch, eds. Direct Oral Anticoagulants. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-74462-5.
Full textMousa, Shaker A. Anticoagulants, Antiplatelets, and Thrombolytics. New Jersey: Humana Press, 2003. http://dx.doi.org/10.1385/1592596584.
Full textMousa, Shaker A., ed. Anticoagulants, Antiplatelets, and Thrombolytics. Totowa, NJ: Humana Press, 2010. http://dx.doi.org/10.1007/978-1-60761-803-4.
Full textA, Mousa Shaker, ed. Anticoagulants, antiplatelets, and thrombolytics. Totowa, N.J: Humana Press, 2004.
Find full textA, Mousa Shaker, ed. Anticoagulants, antiplatelets, and thrombolytics. Totowa, N.J: Humana Press, 2004.
Find full textMousa, Shaker A. Anticoagulants, antiplatelets, and thrombolytics. [Place of publication not identified]: Humana, 2010.
Find full text1934-, Green David, ed. Anticoagulants: Physiologic, pathologic, and pharmacologic. Boca Raton: CRC Press, 1994.
Find full textF, Bruley Duane, and Drohan William, eds. Protein C and related anticoagulants. The Woodlands, Tex: Portfolio Pub. Co., 1990.
Find full textShantsila, Eduard, and Gregory YH Lip. Non-Vitamin K Antagonist Oral Anticoagulants. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-25460-9.
Full textBook chapters on the topic "Anticoagulants"
Yamashita, Tetsushi, and Toshihiro Torato. "Anticoagulants." In The Concise Manual of Apheresis Therapy, 161–74. Tokyo: Springer Japan, 2013. http://dx.doi.org/10.1007/978-4-431-54412-8_16.
Full textÖzkaya, Esen, and Kurtuluş Didem Yazganoğlu. "Anticoagulants." In Adverse Cutaneous Drug Reactions to Cardiovascular Drugs, 195–206. London: Springer London, 2014. http://dx.doi.org/10.1007/978-1-4471-6536-1_14.
Full textShetty, Hamsaraj G. M., and Philip A. Routledge. "Anticoagulants." In Pathy's Principles and Practice of Geriatric Medicine, 357–62. Chichester, UK: John Wiley & Sons, Ltd, 2012. http://dx.doi.org/10.1002/9781119952930.ch31.
Full textHallenbeck, William H., and Kathleen M. Cunningham-Burns. "Anticoagulants." In Pesticides and Human Health, 15. New York, NY: Springer New York, 1985. http://dx.doi.org/10.1007/978-1-4612-5054-8_9.
Full textBhandari, Prasan. "Anticoagulants." In Pharmacology Mind Maps for Medical Students and Allied Health Professionals, 369–78. Boca Raton, FL : CRC Press/Taylor & Francis, 2020.: CRC Press, 2019. http://dx.doi.org/10.1201/9780429023859-40.
Full textFasinu, Pius S., and Stephanie A. Kustos. "Anticoagulants." In Encyclopedia of Molecular Pharmacology, 1–10. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-21573-6_166-1.
Full textScherer Hofmeier, Kathrin. "Anticoagulants." In Cutaneous Drug Hypersensitivity, 223–31. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-82743-4_25.
Full textFasinu, Pius S., and Stephanie A. Kustos. "Anticoagulants." In Encyclopedia of Molecular Pharmacology, 125–34. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-57401-7_166.
Full textPauli, R. M. "Anticoagulants." In Drug Toxicity in Embryonic Development II, 191–229. Berlin, Heidelberg: Springer Berlin Heidelberg, 1997. http://dx.doi.org/10.1007/978-3-642-60447-8_5.
Full textCoons, James C., and Sandeep Devabhakthuni. "Thrombolytics/Anticoagulants." In High-Risk IV Medications in Special Patient Populations, 1–67. London: Springer London, 2011. http://dx.doi.org/10.1007/978-0-85729-606-1_1.
Full textConference papers on the topic "Anticoagulants"
Pengo, V., M. J. Heine, P. Thiagarajan, and s. s. Shapiro. "A GENERAL MECHANISM FOR LUPUS ANTICOAGULANTS." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643660.
Full textHetjens, S., J. Harenberg, and C. Weiss. "Interaction of direct oral anticoagulants and other anticoagulants on DOAC Dipstick test." In 65th Annual Meeting of the Society of Thrombosis and Haemostasis Research. Georg Thieme Verlag KG, 2021. http://dx.doi.org/10.1055/s-0041-1728173.
Full textSagripant, A., A. Carpi, U. Baicchi, A. Nicolini, and M. Ferdeghint. "ORAL ANTICOAGULANTS IN BREAST CANCER PATIENTS." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643671.
Full textMolins, E. Rodriguez, B. Rodríguez de Castro, R. Pampín, B. Fernández González, Y. Labeaga Baramundi, S. Rodríguez Nebreda, and R. Sánchez del Moral. "5PSQ-015 Prescription errors of anticoagulants." In Abstract Book, 23rd EAHP Congress, 21st–23rd March 2018, Gothenburg, Sweden. British Medical Journal Publishing Group, 2018. http://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.369.
Full textSepúlveda, R. López, S. Anaya-Ordóñez, E. Espínola García, MA García Lirola, MS Martín Sances, and J. Cabeza Barrera. "DI-023 Utilisation study of oral anticoagulants (2008–2015) and bleeding due to anticoagulant treatment (2012–2015)." In 22nd EAHP Congress 22–24 March 2017 Cannes, France. British Medical Journal Publishing Group, 2017. http://dx.doi.org/10.1136/ejhpharm-2017-000640.270.
Full textRen, Yujie, and Cheng Du. "The Research on Synthesis Methods of Anticoagulants." In 2012 International Conference on Biomedical Engineering and Biotechnology (iCBEB). IEEE, 2012. http://dx.doi.org/10.1109/icbeb.2012.441.
Full textGavilanes, Francisca, José Leonnidas Alves, Caio JC Fernandes, Luis FL Prada, William Salibe Filho, Mario Terra Filho, Carlos Jardim, and Rogério Souza. "The use of new anticoagulants in CTEPH." In ERS International Congress 2017 abstracts. European Respiratory Society, 2017. http://dx.doi.org/10.1183/1393003.congress-2017.pa2409.
Full textCaspers, M., S. Roeschl, J. Holle, and H. Bendella. "Assessment of the anticoagulant effect of direct oral anticoagulants (DOACs) in patients needing immediate management during emergency procedures." In 65th Annual Meeting of the Society of Thrombosis and Haemostasis Research. Georg Thieme Verlag KG, 2021. http://dx.doi.org/10.1055/s-0041-1728101.
Full textSchofield, K. P., J. M. Thomson, and L. Poller. "PROTEIN C RESPONSE TO INDUCTION AND WITHDRAWAL OF ORAL ANTICOAGULANT TREATMENT." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643273.
Full textCroci, D., M. Dalolio, M. Kamenova, R. Guzman, L. Mariani, S. Schaeren, and J. Soleman. "Novel Oral Anticoagulants in Patients Undergoing Spine Surgery." In Joint Annual Meeting 2018: Swiss Society of Neurosurgery, Swiss Society of Neuroradiology. Georg Thieme Verlag KG, 2018. http://dx.doi.org/10.1055/s-0038-1660764.
Full textReports on the topic "Anticoagulants"
Purba, Abdul, Saraswati Gumilang, Dhihintia Jiwangga, Nurina Hasanatuludhhiyah, and Maarten Postma. Cost and clinical outcomes in the use of new oral anticoagulants versus warfarin in deep vein thrombosis: A systematic review protocol. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, December 2022. http://dx.doi.org/10.37766/inplasy2022.12.0106.
Full textDatta, Soumentra, James Worsfold, and Zafar Maan. Understanding direct oral anticoagulants: an update for urology practice. BJUI Knowledge, July 2019. http://dx.doi.org/10.18591/bjuik.0315.
Full textGillespie, Catherine W., and Leigh Purvis. Novel Anticoagulants Achieve Rapid Market Penetration despite Higher Costs. AARP Public Policy Institute, June 2021. http://dx.doi.org/10.26419/ppi.00100.001.
Full textBiswas, Krishnendu, and Soumendra Datta. Understanding direct oral anticoagulants: an update for urology practice. BJUI Knowledge, January 2023. http://dx.doi.org/10.18591/bjuik.0315.v2.
Full textYe, Hao-Zhen, Jia-Jia Gao, He Zhou, Zhi-Wei Li, Hong-Wei Xu, and Ben Wang. The risk of postpolypectomy bleeding in patients receiving direct oral anticoagulants compared to warfarin or non-anticoagulants: a systematic review with meta-analysis of cohort studies. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, October 2022. http://dx.doi.org/10.37766/inplasy2022.10.0124.
Full textBode, Arthur P. Development of Novel, Reversible, Non-Toxic Anticoagulants for Greatly Extended Platelet Storage. Fort Belvoir, VA: Defense Technical Information Center, September 1988. http://dx.doi.org/10.21236/ada203215.
Full textA, Bengolea, Chamorro F, Ozon N, Catalano HN, and Izcovich A. Effectiveness and safety of utilizing imaging techniques to guide treatment in patients with venous thromboembolism. Epistemonikos Interactive Evidence Synthesis, January 2023. http://dx.doi.org/10.30846/ies.2b03926263.v1.
Full textA, Bengolea, Chamorro F, Ozon N, Catalano HN, and Izcovich A. Effectiveness and safety of utilizing imaging techniques to guide treatment in patients with venous thromboembolism. Epistemonikos Interactive Evidence Synthesis, April 2024. http://dx.doi.org/10.30846/ies.2b03926263.
Full textXu, Zhi-Qiang, Zhi-Hong Xu, and Na Zhang. Comprehensive Systematic Review and Meta-Analysis on Anticoagulants and Aspirin for Stroke Prevention in Non-Valvular Atrial Fibrillation Patients. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, September 2023. http://dx.doi.org/10.37766/inplasy2023.9.0089.
Full textGeng, Yu, Chang Meng, Tong Gao, Siyuan Li, Lei Bi, Yintang Wang, and Ping Zhang. The Efficacy and Safety of Novel Oral Anticoagulants in Pediatric Venous Thromboembolism Treatment and Prevention: systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, December 2022. http://dx.doi.org/10.37766/inplasy2022.12.0065.
Full text